Arrowhead Pharmaceuticals
The Associate Scientist III in the Process Development Chemistry Group focuses on oligonucleotide analysis and synthesis development, supporting new and ongoing projects with a focus on process characterization. The role involves performing analytical techniques, interpreting experimental data, and collaborating with senior chemists to develop new synthetic approaches. The position requires maintaining laboratory documentation, troubleshooting equipment, and communicating progress to management.
Headquarters
Pasadena, California, United States
Company Size
501-1000 employees
Founded
2004
Arrowhead Pharmaceuticals is a clinical-stage biopharmaceutical company that discovers, develops, and delivers RNA interference (RNAi)-based therapeutics to silence disease-causing genes. Using proprietary targeted delivery platforms that enable focused, durable gene knockdown, Arrowhead advances programs across liver and extra‑hepatic indications including cardiometabolic, pulmonary, viral, and rare diseases. The company progresses multiple clinical and preclinical candidates and collaborates with partners to translate RNAi science into new therapies that aim to change how diseases are treated.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Arrowhead Pharmaceuticals.
7% above the average for this role
Oligonucleotide Scientist II
SGA
Principal Scientist III - Synthetic Chemist - FSP
Parexel
Synthetic Molecule Design and Development (SMDD) Chemist
Lilly
Sr. Specialist –Discovery Process Chemistry (P3)
Merck & Co., Inc.
Temporary Research Associate / Scientist
iSi Environmental
Senior Scientist, Oligo Chemistry
Leica Biosystems